Category:

Regulatory

Award, fellowship & grant

Business and Market Strategy

Regulatory

Lupin Receives U.S. FDA Approval for Interchangeable Ranibizumab Biosimilar Ranluspec

Regulatory

FDA Launches One-Day Inspection Pilot to Enhance Risk-Based Oversight

Regulatory

FDA Novel Drug Approvals 2026 Q1: Full List & Insights

book/virender-singh-molecules-mentors-mindsets/

Regulatory

FDA Grants Full Approval to Tecartus CAR-T Therapy for Mantle Cell Lymphoma

Regulatory

FDA Approves drug for Neurologic Symptoms of Hunter Syndrome

Regulatory

FDA Approves Kresladi: First Gene Therapy for Rare Immune Disorder LAD-I

Regulatory

CDSCO Flags 4 Spurious Drugs and 194 Substandard Medicines in February 2026

Regulatory

Immunogenicity Risk Assessment Drives Smarter and Safer Drug Development | EpiVax

Regulatory

FDA Draft Guidance on NAMs Shifts Focus to Validation in Drug Development

Regulatory

FDA Novel Drug Therapy Approvals for 2025 | Quarter 4

Regulatory

FDA Approves New Gene Therapy for Spinal Muscular Atrophy (SMA)

Regulatory

Accord BioPharma Announces FDA Approval of Denosumab Biosimilars

book/virender-singh-molecules-mentors-mindsets/

Applications Open for Prime Minister Research Chair (PMRC) Scheme 2026

June 5, 2026

Artificial Heart Pumps Help Save Three Teenagers Before Heart Transplants at Narayana Health

June 5, 2026

Lupin Receives U.S. FDA Approval for Interchangeable Ranibizumab Biosimilar Ranluspec

June 5, 2026

Antara Launches Integrative Medicine Clinic for Chronic Disease Care in Gurugram

June 5, 2026

Beyond Junk DNA: Sudhakaran Prabakaran on the Dark Genome and Humanity’s Hidden Genetic Potential

June 5, 2026